AxoSim

About

AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform.

New Orleans,Louisiana,United States
11 - 50

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $225K
Industries: Biopharma,Biotechnology,Life Science,Medical,Neuroscience
Founded date: Jan 1, 2014
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: AxoSim, Inc.

AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The company empowers advancements in human neuroscience and accelerates the drug development process through its drug discovery platforms, NerveSim and BrainSim.

AxoSim was founded in 2014 and is based in New Orleans, Louisiana.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

13

$10.50M

AxoSim has raised a total of $10.50M in funding over 2 rounds. Their latest funding was raised on Jun 10, 2021 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 10, 2021	Series Unknown	$6.05M	—	—	—	Detail
May 28, 2021	Series A	—	1	—	—	Detail
Nov 5, 2020	Private Equity（PE）	—	2	—	—	Detail
Jun 1, 2019	Seed	—	1	—	—	Detail
Mar 7, 2019	Series Unknown	$1.13M	1	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

10

AxoSim is funded by 10 investors. National Science Foundation and New Orleans BioFund are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Science Foundation	Yes	Grant
New Orleans BioFund	—	Series A
Benson Capital Partners	—	Private Equity（PE）
Jefferson Capital Partners	—	Private Equity（PE）
Great Stuff Ventures	—	Series Unknown
National Institutes of Health	—	Grant
Lagniappe Angels	—	Seed
Abstraction Ventures	—	Seed
Laconia Ventures	—	Seed
Center for the Advancement of Science in Space	—	Grant